流感免疫印记协同PEI-HA/CpG纳米颗粒疫苗抵抗小鼠异亚型感染
本研究探讨流感免疫印记如何影响PEI-Aichi HA/CpG(PHC)纳米颗粒疫苗接种后的抗体应答及对异亚型病毒攻击的保护。结果发现,预先存在的病毒免疫可维持或协同疫苗诱导的抗体滴度,取决于印记病毒的HA系统发育群。HA第2群病毒(Phi,H3N2)印记小鼠接种后抗体应答更强且更平衡,对异亚型重配A/Shanghai/2/2013(rSH,H7N9)病毒攻击提供完全保护,免于体重下降和肺部炎症。
要点
- HA第2群病毒印记小鼠接种PHC后抗体应答更强且更平衡,对rSH(H7N9)攻击完全保护。
- HA第1群病毒(PR8,H1N1)印记小鼠接种后抗原特异性抗体应答与无印记小鼠相当。
- 流感印记对后续疫苗的协同作用取决于印记病毒与疫苗HA的系统发育群是否一致。
核心结论
- 流感印记来自同一HA系统发育群时可协同后续疫苗接种,提供异亚型保护。
研究设计与样本
- 小鼠实验研究:比较HA第1群病毒(PR8,H1N1)或HA第2群病毒(Phi,H3N2)印记后接种PEI-Aichi HA/CpG(PHC)纳米颗粒疫苗的抗体应答及对异亚型重配A/Shanghai/2/2013(rSH,H7N9)病毒攻击的保护。
主要发现
- HA第1群病毒(PR8,H1N1)印记小鼠接种PHC后抗原特异性抗体应答与无印记小鼠相当。
- HA第2群病毒(Phi,H3N2)印记小鼠接种PHC后抗体应答显著更强且更平衡。
- HA第2群病毒印记小鼠对异亚型重配rSH(H7N9)病毒攻击获得完全保护,免于体重下降和肺部炎症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The first influenza virus infection (imprinting) can lead to long-term immune memory and influence subsequent vaccinations and infections. Previously, we reported a polyethyleneimine (PEI)-Aichi hemagglutinin (HA)/CpG (PHC) nanoparticle with cross-protective potential against homologous and heterologous influenza strains. Here we studied how influenza immune imprinting influences the antibody responses to the PHC vaccination and the protection against heterosubtypic virus challenges. We found that pre-existing virus immunity can maintain or synergize the vaccine-induced antibody titers, depending on the imprinting virus HA phylogenetic group. The HA group 1 virus (PR8, H1N1)-imprinted mice displayed comparable antigen-specific antibody responses to those without imprinting post-PHC vaccination. In contrast, the group 2 virus (Phi, H3N2)-imprinted mice showed significantly more robust and balanced antibodies post-vaccination, conferring complete protection against body weight loss and lung inflammation upon heterosubtypic reassortant A/Shanghai/2/2013 (rSH, H7N9) virus challenge. Our findings suggest that influenza imprinting from the same HA phylogenetic group can synergize subsequent vaccination, conferring heterosubtypic protection.
引用
- Dong C, Ma Y, Zhu W, et al. Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice. Vaccine. 2023. PMID: 38097456. doi:10.1016/j.vaccine.2023.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。